Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Translational Cancer Research|February 4, 2022
Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysisWeibin Lian, Juanjuan Zheng, Debo Chen
Translational Cancer Research|February 4, 2022
Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort studyWeibin Lian, Fangmeng Fu, Debo Chen, et al.
American Journal of Physiology. Cell Physiology|December 23, 2024
USP35 promotes breast cancer progression by regulating PFK-1 ubiquitination to mediate glycolysisWeibin Lian, Chengye Hong, Debo Chen, et al.
BMC Cancer|August 19, 2025
Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective studyWeibin Lian, Liangqiang Li, Chengye Hong, et al.
Scientific Reports|May 17, 2026
Effect of obesity and endocrine therapy on the prognosis of premenopausal women with HR+HER2-breast cancer: a multi-center retrospective studyWeibin Lian, Chengye Hong, Chuan Wang, et al.
BMC Cancer|April 17, 2025
Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a multi-center retrospective studyWeibin Lian, Liangqiang Li, Debo Chen, et al.
Scientific Reports|November 26, 2025
Association between body mass index and efficacy of neoadjuvant targeted therapy in HER2-positive breast cancer in a Chinese multicenter cohortChengye Hong, Peidong Yang, Debo Chen, et al.
Frontiers in Medicine|June 5, 2023
A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancerWeibin Lian, Peidong Yang, Liangqiang Li, et al.
Evolutionary Bioinformatics Online|November 19, 2021
Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot StudyPeidong Yang, Zhitang Wang, Qingqin Peng, et al.
ACS Applied Materials & Interfaces|January 13, 2026
Protein Nanovaccines Co-Delivering STING Agonists for Enhanced Dendritic Cell Activation and Antitumor ImmunityPeidong Yang, Xiaoming Hu, Weibin Lian, et al.
Pageof 3